Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials
2014-01-01 Lorenzetti, R; Zullo, A; Ridola, L; Diamanti, Ap; Laganà, B; Gatta, L; Migliore, A; Armuzzi, Alessandro; Hassan, C; Bruzzese, V.
Non-invasive assessment of human hepatic mitochondrial function through the C-13-methionine breath test
2000-01-01 Armuzzi, A; Marcoccia, S; Zocco, Ma; De Lorenzo, A; Grieco, A; Tondi, P; Pola, P; Gasbarrini, G; Gasbarrini, A
Colorectal cancer screening in Italy: A survey of gastroenterologists' clinical practices
2020-01-01 Cannizzaro, R; 2018 FISMAD Scientific Committee (Cannzzaro, R; Monica, F; Manfredi, G; Radaelli, F; Zagari, Rm; Arcidiacono, Pg; Armuzzi, A; Cavestro, Gm; Biagi, F; Parodi, MC)
Natalizumab in Crohn's disease: past and future areas of applicability
2013-01-01 Armuzzi, A; Felice, C
Italian IBD Patients Coping With Covid-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-care
2020-01-01 Castellini, G; Savarese, M; Leone, S; Previtali, E; Armuzzi, A; Graffigna, G
Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe
2020-01-01 Armuzzi, A; Dibonaventura, Md; Tarallo, M; Lucas, J; Bluff, D; Hoskin, B; Bargo, D; Cappelleri, Jc; Quirk, D; Salese, L
Inducing remission of ulcerative colitis: are clinicians better equipped than ever?
2013-01-01 Armuzzi, Alessandro; Felice, C.
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease
2020-01-01 Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease., Sandborn WJ; Feagan, Bg; Loftus EV, Jr; Peyrin-Biroulet, L; Van Assche, G; D'Haens, G; Schreiber, S; Colombel, Jf; Lewis, Jd; Ghosh, S; Armuzzi, A; Scherl, E; Herfarth, H; Vitale, L; Mohamed, Mf; Othman, Aa; Zhou, Q; Huang, B; Thakkar, Rb; Pangan, Al; Lacerda, Ap; Panes, J
Ileal Crohn's disease: CEUS determination of activity
2012-01-01 De Franco, A; Marzo, M; Felice, C; Pugliese, D; Di Veronica, A; Bonomo, L; Armuzzi, A; Guidi, L
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection
2000-01-01 Cammarota, G; Cannizzaro, O; Ojetti, V; Cianci, R; Pastorelli, A; Armuzzi, A; Gentiloni, N; Gasbarrini, A; Pirozzi, G; Gasbarrini, G
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab
2019-01-01 Favale, A; Onali, S; Caprioli, F; Pugliese, D; Armuzzi, A; Macaluso, Fs; Orlando, A; Viola, A; Fries, W; Rispo, A; Castiglione, F; Mocci, G; Chicco, F; Usai, P; Calabrese, E; Biancone, L; Monteleone, G; Fantini, Mc; Italian Group for the study of Inflammatory Bowel Disease, (IG-IBD)
How clinicians and pathologists interact concerning inflammatory bowel disease in Italy: an IG-IBD survey
2018-01-01 Macaluso, Fs; Orlando, A; Bassotti, G; Rizzo, Ag; Armuzzi, A; Villanacci, V
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients
2021-01-01 Bertani, L; Tricò, D; Pugliese, D; Privitera, G; Linsalata, G; Zanzi, F; Gloria Mumolo, M; Barberio, B; Monzani, F; Marchi, S; Guidi, L; Blandizzi, C; Armuzzi, A; Costa, F
Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists
2017-01-01 Daperno, M; Comberlato, M; Bossa, F; Armuzzi, A; Biancone, L; Bonanomi, Ag; Cosintino, R; Lombardi, G; Mangiarotti, R; Papa, A; Pica, R; Grassano, L; Pagana, G; D'Incà, R; Orlando, A; Rizzello, F; Igibdendo, Group.
Fecal calprotection in first-degree relatives of patients with ulcerative colitis
2009-01-01 Curigliano, V; Montalto, M; Santoro, L; Armuzzi, A; Cammarota, G; Covino, M; D'Onofrio, F; Gallo, A; Gasbarrini, A; Gasbarrini, G
Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts
2017-01-01 Armuzzi, A; Felice, C; Lubrano, E; Cantini, F; Castiglione, F; Gionchetti, P; Orlando, A; Salvarani, C; Scarpa, R; Marchesoni, A; Vecchi, M; Olivieri, I; Italian SpA-IBD Expert Panel, Group.
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study
2020-01-01 Biancone, L; Armuzzi, A; Scribano, Ml; Castiglione, F; D'Incà, R; Orlando, A; Papi, C; Daperno, M; Vecchi, M; Riegler, G; Fries, W; Alvisi, P; Meucci, G; Mocciaro, F; Rogai, F; Festa, S; Guidi, L; Testa, A; Spina, L; Renna, S; Viola, A; Patturelli, M; Di Mitri, R; Frankovic, I; Calabrese, E; Petruzziello, C; De Cristofaro, E; Sena, G; Ruffa, A; Neri, B; Rossi, A
Reply to managing patients with ulcerative colitis with infliximab in primary and referral gastroenterology centers
2014-01-01 Armuzzi, Alessandro; Pugliese, D.
The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19
2021-01-01 Napolitano, D; Privitera, G; Schiavoni, E; Turchini, L; Amatucci, V; Pugliese, D; Gasbarrini, A; Scaldaferri, F; Armuzzi, A
Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?
2014-01-01 Rizzo, Gianluca; Pugliese, Daniela; Armuzzi, Alessandro; Coco, Claudio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials | 1-gen-2014 | Lorenzetti, R; Zullo, A; Ridola, L; Diamanti, Ap; Laganà, B; Gatta, L; Migliore, A; Armuzzi, Alessandro; Hassan, C; Bruzzese, V. | |
| Non-invasive assessment of human hepatic mitochondrial function through the C-13-methionine breath test | 1-gen-2000 | Armuzzi, A; Marcoccia, S; Zocco, Ma; De Lorenzo, A; Grieco, A; Tondi, P; Pola, P; Gasbarrini, G; Gasbarrini, A | |
| Colorectal cancer screening in Italy: A survey of gastroenterologists' clinical practices | 1-gen-2020 | Cannizzaro, R; 2018 FISMAD Scientific Committee (Cannzzaro, R; Monica, F; Manfredi, G; Radaelli, F; Zagari, Rm; Arcidiacono, Pg; Armuzzi, A; Cavestro, Gm; Biagi, F; Parodi, MC) | |
| Natalizumab in Crohn's disease: past and future areas of applicability | 1-gen-2013 | Armuzzi, A; Felice, C | |
| Italian IBD Patients Coping With Covid-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-care | 1-gen-2020 | Castellini, G; Savarese, M; Leone, S; Previtali, E; Armuzzi, A; Graffigna, G | |
| Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe | 1-gen-2020 | Armuzzi, A; Dibonaventura, Md; Tarallo, M; Lucas, J; Bluff, D; Hoskin, B; Bargo, D; Cappelleri, Jc; Quirk, D; Salese, L | |
| Inducing remission of ulcerative colitis: are clinicians better equipped than ever? | 1-gen-2013 | Armuzzi, Alessandro; Felice, C. | |
| Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease | 1-gen-2020 | Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease., Sandborn WJ; Feagan, Bg; Loftus EV, Jr; Peyrin-Biroulet, L; Van Assche, G; D'Haens, G; Schreiber, S; Colombel, Jf; Lewis, Jd; Ghosh, S; Armuzzi, A; Scherl, E; Herfarth, H; Vitale, L; Mohamed, Mf; Othman, Aa; Zhou, Q; Huang, B; Thakkar, Rb; Pangan, Al; Lacerda, Ap; Panes, J | |
| Ileal Crohn's disease: CEUS determination of activity | 1-gen-2012 | De Franco, A; Marzo, M; Felice, C; Pugliese, D; Di Veronica, A; Bonomo, L; Armuzzi, A; Guidi, L | |
| Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection | 1-gen-2000 | Cammarota, G; Cannizzaro, O; Ojetti, V; Cianci, R; Pastorelli, A; Armuzzi, A; Gentiloni, N; Gasbarrini, A; Pirozzi, G; Gasbarrini, G | |
| Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab | 1-gen-2019 | Favale, A; Onali, S; Caprioli, F; Pugliese, D; Armuzzi, A; Macaluso, Fs; Orlando, A; Viola, A; Fries, W; Rispo, A; Castiglione, F; Mocci, G; Chicco, F; Usai, P; Calabrese, E; Biancone, L; Monteleone, G; Fantini, Mc; Italian Group for the study of Inflammatory Bowel Disease, (IG-IBD) | |
| How clinicians and pathologists interact concerning inflammatory bowel disease in Italy: an IG-IBD survey | 1-gen-2018 | Macaluso, Fs; Orlando, A; Bassotti, G; Rizzo, Ag; Armuzzi, A; Villanacci, V | |
| Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients | 1-gen-2021 | Bertani, L; Tricò, D; Pugliese, D; Privitera, G; Linsalata, G; Zanzi, F; Gloria Mumolo, M; Barberio, B; Monzani, F; Marchi, S; Guidi, L; Blandizzi, C; Armuzzi, A; Costa, F | |
| Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists | 1-gen-2017 | Daperno, M; Comberlato, M; Bossa, F; Armuzzi, A; Biancone, L; Bonanomi, Ag; Cosintino, R; Lombardi, G; Mangiarotti, R; Papa, A; Pica, R; Grassano, L; Pagana, G; D'Incà, R; Orlando, A; Rizzello, F; Igibdendo, Group. | |
| Fecal calprotection in first-degree relatives of patients with ulcerative colitis | 1-gen-2009 | Curigliano, V; Montalto, M; Santoro, L; Armuzzi, A; Cammarota, G; Covino, M; D'Onofrio, F; Gallo, A; Gasbarrini, A; Gasbarrini, G | |
| Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts | 1-gen-2017 | Armuzzi, A; Felice, C; Lubrano, E; Cantini, F; Castiglione, F; Gionchetti, P; Orlando, A; Salvarani, C; Scarpa, R; Marchesoni, A; Vecchi, M; Olivieri, I; Italian SpA-IBD Expert Panel, Group. | |
| Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study | 1-gen-2020 | Biancone, L; Armuzzi, A; Scribano, Ml; Castiglione, F; D'Incà, R; Orlando, A; Papi, C; Daperno, M; Vecchi, M; Riegler, G; Fries, W; Alvisi, P; Meucci, G; Mocciaro, F; Rogai, F; Festa, S; Guidi, L; Testa, A; Spina, L; Renna, S; Viola, A; Patturelli, M; Di Mitri, R; Frankovic, I; Calabrese, E; Petruzziello, C; De Cristofaro, E; Sena, G; Ruffa, A; Neri, B; Rossi, A | |
| Reply to managing patients with ulcerative colitis with infliximab in primary and referral gastroenterology centers | 1-gen-2014 | Armuzzi, Alessandro; Pugliese, D. | |
| The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19 | 1-gen-2021 | Napolitano, D; Privitera, G; Schiavoni, E; Turchini, L; Amatucci, V; Pugliese, D; Gasbarrini, A; Scaldaferri, F; Armuzzi, A | |
| Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery? | 1-gen-2014 | Rizzo, Gianluca; Pugliese, Daniela; Armuzzi, Alessandro; Coco, Claudio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891